Cvs Caremark Corp (CVS) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2011

Exhibit 99.1

FOR IMMEDIATE RELEASE

CVS CAREMARK REPORTS FOURTH QUARTER AND FULL YEAR RESULTS

2012 GUIDANCE RAISED TO REFLECT ANTICIPATED FIRST QUARTER BENEFIT OF PRESCRIPTION TRANSFERS FROM WALGREENS

Fourth Quarter Year-Over-Year Highlights:

·                  Net revenues increased 15.2% to a record $28.3 billion, with Pharmacy Services up 32.4% and Retail Pharmacy up 4.0%

·                  Retail Pharmacy segment same stores sales increased 2.5%

·                  Adjusted EPS of $0.89, up 16.2% excluding $0.03 per share tax benefit in prior year; GAAP diluted EPS from continuing operations of $0.84

Full Year Highlights:

·                  Net revenues increased 11.8% to a record $107.1 billion, with Pharmacy Services up 24.9% and Retail Pharmacy up 3.9%

·                  Retail Pharmacy segment same store sales increased 2.3%

·                  Adjusted EPS of $2.80, up 5.9% excluding $0.03 per share tax benefit in prior year; GAAP diluted EPS from continuing operations of $2.59

·                  Generated free cash flow of $4.6 billion; cash flow from operations of $5.9 billion

2012 Guidance:

·                  Full-year Adjusted EPS of $3.18 to $3.28; GAAP diluted EPS from continuing operations of $2.96 to 3.06

·                  First quarter Adjusted EPS from continuing operations of $0.61 to $0.63; GAAP diluted EPS from continuing operations of $0.55 to $0.57

·                  Expect to generate full year free cash flow of $4.6 to $4.9 billion; cash flow from operations of $6.2 to $6.4 billion

WOONSOCKET, RHODE ISLAND, February 8, 2012 - CVS Caremark Corporation (NYSE: CVS) today announced revenues, operating profit and net income for the three months and year ended December 31, 2011.

Revenues

Net revenues for the three months ended December 31, 2011, increased 15.2% or $3.7 billion, to $28.3 billion, up from $24.6 billion in the three months ended December 31, 2010. For the year ended December 31, 2011, total revenue increased 11.8% or $11.3 billion, to $107.1 billion, compared to $95.8 billion for the year ended December 31, 2010.

1